Pad Chivukula is listed as an executive officer and director on 1 SEC Form D filing by 1 issuer in Jan 2018: Arcturus Therapeutics Ltd. (San Diego, CA — biotechnology — 2018; $67.8M reported sold to 82 investors).
What this means One deal on file with the SEC, filed Jan 2018. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Craig Willett (1 shared filing), DAVID SHAPIRO (1 shared filing), Daniel Geffken (1 shared filing), Joseph Edward Payne (1 shared filing), Orli Tori (1 shared filing) and 1 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Pad. Each name links to their own page.
The issuer belongs to the sponsor group Arcturus Therapeutics (2 issuers, $73.7M reported sold, 2013–2018).
What this means A sponsor group is one team that sets up a new company for each deal. Arcturus Therapeutics has 2 companies on file and $73.7M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 court cases matching the name listed in Key records below.
What this means 3 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Pad Chivukula and found 1 difference: Form D filed 50 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.